Company / Free Cash Flow per Share
Adaptive Biotechnologies Corp Free Cash Flow per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$0.33
FY2025
5-year range
-$1.85 / -$0.33
FY2021-FY2025
Trend
+51.4%
vs FY2024
Sector context
#79 of 192
Health Care
What the data says
At $-0.33, Adaptive Biotechnologies Corp's free cash flow per share ranks #79 of 192 in the Health Care sector. Free Cash Flow per Share has increased for 4 consecutive years, from $-1.85 in FY2021 to $-0.33 in FY2025.
Based on SEC 10-K filings.
-0.33 in FY2025.
Improved from $-1.17 to $-0.33 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#79 of 192 in Health CareTop 41% of 192This company -$0.33 Sector average $3.32
▼
-110.0% below sector average
Key checks
Key Insights
- Adaptive Biotechnologies Corp's free cash flow per share has grown for 4 consecutive years.
- In FY2025, free cash flow per share increased 51.4% year-over-year.
- Ranks #79 out of 192 companies in the Health Care sector.
- Peak free cash flow per share was recorded in FY2019.
Company context
Key Data Points
- Altman Z-Score -1.45 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.33 | +51.4% |
| FY2024 | -$0.68 | +41.6% |
| FY2023 | -$1.17 | +17.6% |
| FY2022 | -$1.42 | +23.4% |
| FY2021 | -$1.85 | -37.4% |
| FY2020 | -$1.35 | -108.9% |
| FY2019 | $15.12 | +595.4% |
| FY2018 | -$3.05 | +0.1% |
| FY2017 | -$3.06 | - |
As of FY2025 · SEC 10-K · Updated Jul 1, 2026